Novel inhibitors for murine and human leukemia inhibitory factor based on fused soluble receptors (Q40028531)

16 September 2017

title

Novel inhibitors for murine and human leukemia inhibitory factor based on fused soluble receptors (English)

1 reference

16 September 2017

4

Gerhard Müller-Newen

0 references

author name string

Silke Metz

series ordinal

1

1 reference

16 September 2017

Gudrun Naeth

series ordinal

2

1 reference

16 September 2017

Peter C Heinrich

series ordinal

3

1 reference

16 September 2017

language of work or name

English

0 references

publication date

3 January 2008

1 reference

Journal of Biological Chemistry

16 September 2017

published in

1 reference

16 September 2017

volume

283

1 reference

16 September 2017

issue

10

1 reference

16 September 2017

page(s)

5985-5995

1 reference

Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

A fusion protein of the gp130 and interleukin-6Ralpha ligand-binding domains acts as a potent interleukin-6 inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

Characterization of the Interleukin (IL)-6 Inhibitor IL-6-RFP: fused receptor domains act as high affinity cytokine-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

Cytokine traps: multi-component, high-affinity blockers of cytokine action

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

The family of the IL-6-type cytokines: specificity and promiscuity of the receptor complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

Interleukin-6: structure-function relationships.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

Long term association of the cytokine receptor gp130 and the Janus kinase Jak1 revealed by FRAP analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

Convergent mechanisms for recognition of divergent cytokines by the shared signaling receptor gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

The membrane distal half of gp130 is responsible for the formation of a ternary complex with IL-6 and the IL-6 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

A major binding protein for leukemia inhibitory factor in normal mouse serum: identification as a soluble form of the cellular receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

Separate functions for the two modules of the membrane-proximal cytokine binding domain of glycoprotein 190, the leukemia inhibitory factor low affinity receptor, in ligand binding and receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

Membrane distal cytokine binding domain of LIFR interacts with soluble CNTFR in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

The N-terminal cytokine binding domain of LIFR is required for CNTF binding and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

Single-step purification and structural characterization of human interleukin-6 produced in Escherichia coli from a T7 RNA polymerase expression vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

Production of hybridoma growth factor by human monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

Soluble human interleukin-6 receptor. Expression in insect cells, purification and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

LIF and OM directly interact with a soluble form of gp130, the IL-6 receptor signal transducing subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

Molecular and functional characterization of a soluble form of oncostatin M/interleukin-31 shared receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

Mutations in the immunoglobulin-like domain of gp190, the leukemia inhibitory factor (LIF) receptor, increase or decrease its affinity for LIF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

An unusual cytokine:Ig-domain interaction revealed in the crystal structure of leukemia inhibitory factor (LIF) in complex with the LIF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

Molecular phylogeny within type I cytokines and their cognate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

Role of cytokines in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

Leukemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

Increased levels of leukemia inhibitory factor in synovial fluid from patients with rheumatoid arthritis and other inflammatory arthritides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

In vitro evaluation of leukemia inhibitory factor receptor antagonists as candidate therapeutics for inflammatory arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

The production of leukaemia inhibitory factor by human endometrium: presence in uterine flushings and production by cells in culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

Localization of leukemia inhibitory factor and its receptor in human placenta throughout pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

Structure of the extracellular domains of the human interleukin-6 receptor alpha -chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706610200

21 January 2018

Identifiers

DOI

10.1074/JBC.M706610200

1 reference

16 September 2017

1 reference